Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
439.2 INR | -3.51% | -9.69% | +21.87% |
20/05 | Solara Active Pharma Gets Zero Observations from US FDA for Andhra Pradesh, India Unit | MT |
10/05 | Solara Active Pharma to Raise 4.50 Billion Via Rights Issue | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+21.87% | 26Cr | |
+38.51% | 73TCr | |
+32.13% | 59TCr | |
-6.23% | 35TCr | |
+18.78% | 33TCr | |
+1.35% | 28TCr | |
+14.68% | 24TCr | |
+8.13% | 21TCr | |
-5.64% | 20TCr | |
+6.19% | 16TCr |
- Stock Market
- Equities
- SOLARA Stock
- News Solara Active Pharma Sciences Limited
- Transcript : Solara Active Pharma Sciences Limited, Q1 2022 Earnings Call, Aug 04, 2021